ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

K. Lentine,1 A. Naik,2 R. Ouseph,1 Z. Zhang,1 D. Axelrod,3 D. Segev,4 V. Dharnidharka,5 D. Brennan,5 H. Randall,1 R. Gadi,1 N. Lam,6 G. Hess,7 M. Schnitzler,1,8 B. Kasiske.8

1St. Louis Univ, St. Louis
2U of Michigan, Ann Arbor
3East Carolina Univ, Greenville
4Johns Hopkins, Baltimore
5Washington Univ, St. Louis
6Univ Alberta, Edmonton, Canada
7Symphony Health, Philadelphia
8Scientific Registry of Transplant Recipients, Minneapolis

Meeting: 2017 American Transplant Congress

Abstract number: 91

Keywords: Kidney, Mortality, Pain, Risk factors

Session Information

Session Name: Concurrent Session: Psychosocial and Mediation Adherence Concerns

Session Type: Concurrent Session

Date: Sunday, April 30, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:54pm-3:06pm

Location: E271b

Limited data are available on the implications of antidepressant medication use in kidney transplant recipients.

We examined a novel database wherein national transplant registry identifiers for kidney transplant recipients were linked to records from a large US pharmaceutical claims warehouse (2008 to 2015). We selected recipients with 1 year of pretransplant pharmaceutical fill records for primary analyses. Associations of antidepressant use with 1-year posttransplant death and graft failure (adjusted hazard ratio, 95% LCL aHR 95% UCL) were quantified by multivariate Cox regression including adjustment for recipient, donor, and transplant factors, and propensity for antidepressant use.

Among 72,054 eligible patients, 12.6% filled antidepressant medications in the year before transplant, and use was more common among recipients who were women, white, unemployed, or of limited functional status. Pretransplant antidepressant use was associated with 39% higher 1-year mortality (aHR 1.181.391.64) and 15% higher all-cause graft loss risk (aHR 1.021.151.30) (Fig 1A). More than 50% of patients who filled antidepressants pretransplant continued use posttransplant. Antidepressant use in the first year after transplant was associated with approximately 2-fold higher risk of death (aHR 1.601.942.35), 38% higher risk of death-censored graft failure, and 61% higher risk of all-cause graft failure risk over the subsequent year (Fig 1B).While associations may in part reflect underlying behaviors or comorbidity, kidney transplant recipients who are treated with antidepressant medications should be monitored and supported to reduce the risk of adverse patient and graft outcomes.

CITATION INFORMATION: Lentine K, Naik A, Ouseph R, Zhang Z, Axelrod D, Segev D, Dharnidharka V, Brennan D, Randall H, Gadi R, Lam N, Hess G, Schnitzler M, Kasiske B. Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lentine K, Naik A, Ouseph R, Zhang Z, Axelrod D, Segev D, Dharnidharka V, Brennan D, Randall H, Gadi R, Lam N, Hess G, Schnitzler M, Kasiske B. Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/antidepressant-medication-use-before-and-after-kidney-transplant-implications-for-post-transplant-outcomes/. Accessed May 13, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences